Cargando...
Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761(®)
BACKGROUND: The Ginkgo biloba special extract, EGb 761(®) has been widely used in the treatment of neuropsychiatric disorders, including Alzheimer’s disease (AD). METHODS: To guide clinical practice in the Asian region, the Asian Clinical Expert Group on Neurocognitive Disorders compiled evidence‐ba...
Gardado en:
| Publicado en: | CNS Neurosci Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6488894/ https://ncbi.nlm.nih.gov/pubmed/30648358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13095 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|